HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system

BACKGROUND: European guidelines for cervical cancer screening now recommend the use of clinically validated assays for high-risk HPV-DNA sequences as primary test in women older than 30 years, performed in centralized laboratories, and run on systems providing automated solutions for all steps. METH...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Womens Health
Hoofdauteurs: Frayle, Helena, Gori, Silvia, Rizzi, Martina, Graziani, Bianca Nives, Vian, Elisa, Giorgi Rossi, Paolo, Del Mistro, Annarosa
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2019
Onderwerpen:
Technical Advance
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6434866/
https://ncbi.nlm.nih.gov/pubmed/30909894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12905-019-0743-0
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items